Inderpal Gujral, MD
Cardiovascular Disease · Laguna Hills, CANPI 1063416410
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,659 of the $9,942 with a category attached, or 77.0%. Biotronik Inc. accounts for 76.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $8,604 and has fallen 97.9% since, to $179 in 2025.
Across 66 payments — averaging $150.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$8K
- Medtronic$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$476
- Abbott$152
- Kiniksa Pharmaceuticals, Ltd.$122
- E.r. Squibb & Sons, L.L.C.$120
- plus $348 from 7 others
Across 1 payment — averaging $765.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$765
What the payments were for
- Consulting fees$1852%
- Speaking & faculty fees$7,65977%
- Travel & lodging$1,01910%
- Food & beverage$1,07911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 3 | $7,580 |
| Medtronic(2 entities) | 8 | $1,144 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 38 | $476 |
| Abbott | 4 | $152 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Analog Devices Inc. | 1 | $115 |
| United Therapeutics Corporation | 1 | $100 |
| Kestra Medical Technology Services, Inc. | 1 | $33 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $31 |
| BD | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,942 in reported general payments places this provider in the 75th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $53,424 |
| XareltoRivaroxaban | 33 | $31,450 |
| EntrestoSacubitril/Valsartan | 15 | $14,610 |
| Furosemide | 84 | $622 |
| Amlodipine Besylate | 29 | $407 |
| Metoprolol Tartrate | 52 | $339 |
| Digoxin | 25 | $280 |
| Diltiazem Hcl | 12 | $263 |
| Metoprolol Succinate | 20 | $257 |
| Potassium Chloride | 15 | $224 |
| Carvedilol | 33 | $190 |
| Amiodarone Hcl | 11 | $190 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $155 |
| ClopidogrelClopidogrel Bisulfate | 13 | $121 |
| Lisinopril | 34 | $116 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Laguna Hills
- Roxana GhashghaeiLaguna Hills$398K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.